Skip to main content

Published locations for FDA okays spesolimab, first treatment for generalized pustular psoriasis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA okays spesolimab, first treatment for generalized pustular psoriasis

User login

  • Reset your password
  • /content/fda-okays-spesolimab-first-treatment-generalized-pustular-psoriasis
  • /edermatologynews/article/257570/psoriasis/fda-okays-spesolimab-first-treatment-generalized-pustular
  • /internalmedicinenews/article/257570/psoriasis/fda-okays-spesolimab-first-treatment-generalized
  • /rheumatologynews/article/257570/psoriasis/fda-okays-spesolimab-first-treatment-generalized-pustular
  • /rheumatology/article/257570/psoriasis/fda-okays-spesolimab-first-treatment-generalized-pustular
  • /internalmedicine/article/257570/psoriasis/fda-okays-spesolimab-first-treatment-generalized-pustular
  • /dermatology/article/257570/psoriasis/fda-okays-spesolimab-first-treatment-generalized-pustular
  • /emergencymedicine/article/257570/psoriasis/fda-okays-spesolimab-first-treatment-generalized-pustular